Search results

We are listening to your views on this Medical technologies guidance. Comments close 16 June 2022.

Type

Medical technologies guidance

Status

In consultation

We are listening to your views on this Interventional procedures guidance. Comments close 24 May 2022.

Type

Interventional procedures guidance

Status

In consultation

We are listening to your views on this Technology appraisal guidance. Comments close 26 May 2022.

Type

Technology appraisal guidance

Status

In consultation

We are listening to your views on this Technology appraisal guidance. Comments close 16 November 2021.

Type

Technology appraisal guidance

Status

In consultation

We are listening to your views on this Technology appraisal guidance. Comments close 6 June 2022.

Type

Technology appraisal guidance

Status

In consultation

We are listening to your views on this Technology appraisal guidance. Comments close 13 June 2022.

Type

Technology appraisal guidance

Status

In consultation

We are listening to your views on this Technology appraisal guidance. Comments close 17 June 2022.

Type

Technology appraisal guidance

Status

In consultation

Evidence-based recommendations on ataluren (Translarna) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene in people aged

Type

Highly specialised technologies guidance

Published

20 July 2016

Evidence-based recommendations on selumetinib (Koselugo) for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over

Type

Highly specialised technologies guidance

Published

05 May 2022

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020

Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults

Type

Highly specialised technologies guidance

Published

24 February 2021

Evidence-based recommendations on eculizumab (Soliris) for treating atypical haemolytic uraemic syndrome in adults and children

Type

Highly specialised technologies guidance

Published

28 January 2015

Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies

Type

Highly specialised technologies guidance

Published

07 July 2021

Evidence-based recommendations on givosiran (Givlaari) for treating acute hepatic porphyria in adults and young people aged 12 and over

Type

Highly specialised technologies guidance

Published

24 November 2021

Evidence-based recommendations on odevixibat (Bylvay) for treating progressive familial intrahepatic cholestasis in people 6 months and older

Type

Highly specialised technologies guidance

Published

22 February 2022

Evidence-based recommendations on atidarsagene autotemcel (Libmeldy) for treating metachromatic leukodystrophy in children

Type

Highly specialised technologies guidance

Published

28 March 2022

Evidence-based recommendations on migalastat (Galafold) for treating Fabry disease in people over 16

Type

Highly specialised technologies guidance

Published

22 February 2017

Evidence-based recommendations on elosulfase alfa (Vimizim) for treating mucopolysaccharidosis type 4A in people of all ages

Type

Highly specialised technologies guidance

Published

20 April 2022

Evidence-based recommendations on inotersen (Tegsedi) for stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis

Type

Highly specialised technologies guidance

Published

22 May 2019

Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people

Type

Highly specialised technologies guidance

Published

10 October 2018

Evidence-based recommendation on Strimvelis for adenosine deaminase deficiency–severe combined immunodeficiency

Type

Highly specialised technologies guidance

Published

07 February 2018

Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in adults and children

Type

Highly specialised technologies guidance

Published

02 August 2017

Evidence-based recommendations on eliglustat (Cerdelga) for treating type 1 Gaucher disease in adults

Type

Highly specialised technologies guidance

Published

28 June 2017

Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children

Type

Highly specialised technologies guidance

Published

27 November 2019

Evidence-based recommendations on voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophies in people with vision loss caused by inherit

Type

Highly specialised technologies guidance

Published

09 October 2019

Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy

Type

Highly specialised technologies guidance

Published

14 August 2019

Evidence-based recommendations on gammaCore for cluster headache

Type

Medical technologies guidance

Published

03 December 2019

Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers

Type

Medical technologies guidance

Published

07 March 2022

Evidence-based recommendations on Prontosan for treating acute and chronic wounds

Type

Medical technologies guidance

Published

08 March 2022

Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections

Type

Medical technologies guidance

Published

13 December 2021

Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography

Type

Medical technologies guidance

Last updated

19 May 2021

Evidence-based recommendations on Plus Sutures for preventing surgical site infection

Type

Medical technologies guidance

Published

28 June 2021

Evidence-based recommendations on KardiaMobile for detecting atrial fibrillation

Type

Medical technologies guidance

Published

06 January 2022

Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography

Type

Medical technologies guidance

Published

04 October 2021

Evidence-based recommendations on Endo-SPONGE for treating low rectal anastomotic leak

Type

Medical technologies guidance

Published

16 December 2021

Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure

Type

Medical technologies guidance

Last updated

21 July 2021

Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy

Type

Medical technologies guidance

Published

10 September 2018

Evidence-based recommendations on iFuse for treating chronic sacroiliac joint pain

Type

Medical technologies guidance

Published

02 October 2018

Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia

Type

Medical technologies guidance

Published

08 February 2017

Evidence-based recommendations on Memokath-051 stent for treating ureteric obstruction

Type

Medical technologies guidance

Published

01 February 2018

Evidence-based recommendations on Thopaz+ for managing chest drains

Type

Medical technologies guidance

Published

21 March 2018

Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C

Type

Medical technologies guidance

Last updated

17 January 2020

Evidence-based recommendations on Spectra Optia for automated red blood cell exchange in people with sickle cell disease

Type

Medical technologies guidance

Published

02 March 2016

Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia

Type

Medical technologies guidance

Published

14 June 2016

Evidence-based recommendations on the XprESS multi-sinus dilation system for treating chronic sinusitis after medical treatment has failed

Type

Medical technologies guidance

Published

13 December 2016

Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain

Type

Medical technologies guidance

Published

23 January 2019

Evidence-based recommendations on Curos for preventing infections when using needleless connectors

Type

Medical technologies guidance

Published

09 May 2019

Evidence-based decisions on Endocuff Vision for assisting visualisation during colonoscopy

Type

Medical technologies guidance

Published

07 June 2019

Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy

Type

Medical technologies guidance

Published

11 February 2020

Evidence-based recommendations on the Ambu aScope4 Broncho for use in unexpected difficult airways

Type

Medical technologies guidance

Last updated

17 June 2019